1. Home
  2. KMDA vs OOMA Comparison

KMDA vs OOMA Comparison

Compare KMDA & OOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • OOMA
  • Stock Information
  • Founded
  • KMDA 1990
  • OOMA 2003
  • Country
  • KMDA Israel
  • OOMA United States
  • Employees
  • KMDA N/A
  • OOMA N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • OOMA EDP Services
  • Sector
  • KMDA Health Care
  • OOMA Technology
  • Exchange
  • KMDA Nasdaq
  • OOMA Nasdaq
  • Market Cap
  • KMDA 349.6M
  • OOMA 296.9M
  • IPO Year
  • KMDA N/A
  • OOMA 2015
  • Fundamental
  • Price
  • KMDA $5.80
  • OOMA $14.54
  • Analyst Decision
  • KMDA Strong Buy
  • OOMA Strong Buy
  • Analyst Count
  • KMDA 2
  • OOMA 6
  • Target Price
  • KMDA $14.50
  • OOMA $16.60
  • AVG Volume (30 Days)
  • KMDA 31.3K
  • OOMA 171.5K
  • Earning Date
  • KMDA 11-13-2024
  • OOMA 12-04-2024
  • Dividend Yield
  • KMDA N/A
  • OOMA N/A
  • EPS Growth
  • KMDA 124.29
  • OOMA N/A
  • EPS
  • KMDA 0.27
  • OOMA N/A
  • Revenue
  • KMDA $158,380,000.00
  • OOMA $253,431,000.00
  • Revenue This Year
  • KMDA $15.38
  • OOMA $10.50
  • Revenue Next Year
  • KMDA $6.18
  • OOMA $6.09
  • P/E Ratio
  • KMDA $21.16
  • OOMA N/A
  • Revenue Growth
  • KMDA 4.52
  • OOMA 9.45
  • 52 Week Low
  • KMDA $4.74
  • OOMA $6.50
  • 52 Week High
  • KMDA $6.53
  • OOMA $17.00
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 46.35
  • OOMA 56.91
  • Support Level
  • KMDA $5.75
  • OOMA $14.35
  • Resistance Level
  • KMDA $5.90
  • OOMA $15.71
  • Average True Range (ATR)
  • KMDA 0.17
  • OOMA 0.60
  • MACD
  • KMDA -0.04
  • OOMA -0.13
  • Stochastic Oscillator
  • KMDA 20.66
  • OOMA 20.63

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About OOMA Ooma Inc.

Ooma Inc is a communications services company. It is a smart software-as-a-service ("SaaS") and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. Ooma generates revenues from the sale of subscriptions and other services.

Share on Social Networks: